Victoza (liraglutide) was approved June 17, 2019, for pediatric patients 10 years of age and older for the treatment of type 2 diabetes. This is the first non-insulin drug approved to treat type 2 diabetes in children since metformin was approved for pediatric patients in 2000.
Carrer de Dos de Maig 283, Barcelona
La dirección Carrer de Dos de Maig 283, Barcelona alberga un laboratorio biotecnológico muy reconocido, de alta calidad, moderno, eficiente y equipado con tecnología de última generación. The address Carrer de Dos de Maig 283, Read more